Filing Details
- Accession Number:
- 0000899243-16-036261
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-22 16:59:56
- Reporting Period:
- 2016-12-21
- Filing Date:
- 2016-12-22
- Accepted Time:
- 2016-12-22 16:59:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654363 | J. Michael Ambrogi | C/O Novocure Inc., 20 Valley Stream Pkwy Suite 300 Malvern PA 19355 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2016-12-21 | 20,000 | $8.33 | 139,084 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2016-12-22 | 7,500 | $8.09 | 131,584 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- On December 21, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.075 to $8.65. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On December 22, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 7,500 shares in multiple trades at prices ranging from $8.00 to $8.175. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
